Damora Therapeutics (DMRA) Amortizatization of Intangibles (2021 - 2024)
Damora Therapeutics (DMRA) posted Amortizatization of Intangibles of -$82000.0 for Q2 2024, down 783.33% on a QoQ basis from $12000.0 in Q1 2024, and down 187.23% year-over-year from $94000.0 in Q3 2023.
Damora Therapeutics (DMRA) Amortizatization of Intangibles (2021 - 2024) Analysis & Trends
Damora Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$82000.0 for Q2 2024.
- Quarterly Amortizatization of Intangibles fell 187.23% year-over-year to -$82000.0 in Q2 2024, while the trailing twelve-month figure through Dec 2024 was -$70000.0 (down 116.24% YoY) and the FY2024 annual result came in at -$70000.0, down 116.24% from the prior year.
- Amortizatization of Intangibles was -$82000.0 for Q2 2024 at Damora Therapeutics, down from $12000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $158000.0 in Q3 2023 and bottomed at -$497000.0 in Q3 2021.
- A 4-year average of -$91214.3 and a median of -$45500.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2022 — Amortizatization of Intangibles plunged 386.96% — and 2023, when it soared 1855.56%.
- Damora Therapeutics' Amortizatization of Intangibles stood at -$341000.0 in 2021, then soared by 65.1% to -$119000.0 in 2022, then surged by 121.01% to $25000.0 in 2023, then slumped by 428.0% to -$82000.0 in 2024.
- Business Quant data shows DMRA's Amortizatization of Intangibles at -$82000.0 in Q2 2024, $12000.0 in Q1 2024, and $25000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Damora Therapeutics | 1.01 Bn | 807.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -82,000.00 |
| Jun 30, 2024 | -82,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Sep 30, 2023 | 158,000.00 |
| Jun 30, 2023 | 94,000.00 |
| Jun 30, 2023 | 94,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Mar 31, 2023 | 154,000.00 |
| Dec 31, 2022 | -119,000.00 |
| Dec 31, 2022 | -119,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Sep 30, 2022 | -9,000.00 |
| Jun 30, 2022 | -174,000.00 |
| Jun 30, 2022 | -174,000.00 |
| Mar 31, 2022 | -264,000.00 |
| Mar 31, 2022 | -264,000.00 |